ARTICLE | Distillery Techniques
Assays and screens
January 2, 2018 9:59 PM UTC
A low-cost computational method for quantifying tumor cfDNA could identify cancer patients eligible for high-cost, whole-exome sequencing-based personalized medicine. The method quantifies tumor cfDNA...
BCIQ Company Profiles